They attach some degree of import to the EU clinical trials in a balanced update. Suggest good figures from this will provide short term catalyst, and have rerated to BUY with target price adjusted from 0.70 to 0.94.
Will be interesting to see what credibility punters give this in the current climate...
Rgds,
Lilac
They attach some degree of import to the EU clinical trials in a...
Add to My Watchlist
What is My Watchlist?